Identification of the ‘NORE’ (N-Oct-3 responsive element), a novel structural motif and composite element

N-Oct-3 is a neuronal transcription factor widely expressed in the developing mammalian central nervous system, and necessary to maintain neural cell differentiation. The key role of N-Oct-3 in the transcriptional regulation of a multiplicity of genes is primarily due to the structural plasticity of its so-called ‘POU’ (acronym of Pit, Oct, Unc) DNA-binding domain. We have recently reported about the unusual dual neuro-specific transcriptional regulation displayed by N-Oct-3 [Blaud,M., Vossen,C., Joseph,G., Alazard,R., Erard,M. and Nieto,L. (2004) J. Mol. Biol., 339, 1049–1058]. To elucidate the underlying molecular mechanisms, we have now made use of molecular modeling, DNA footprinting and electrophoretic mobility shift assay techniques. This combined approach has allowed us to uncover a novel mode of homodimerization adopted by the N-Oct-3 POU domain bound to the neuronal aromatic amino acids de-carboxylase and corticotropin-releasing hormone gene promoters and to demonstrate that this pattern is induced by a structural motif that we have termed ‘NORE’ (N-Oct-3 responsive element), comprising the 14 bp sequence element TNNRTAAATAATRN. In addition, we have been able to explain how the same structural motif can also induce the formation of a heterodimer in association with hepatocyte nuclear factor 3β(/Forkhead box a2). Finally, we discuss the possible role of the NORE motif in relation to neuroendocrine lung tumor formation, and in particular the development of small cell lung cancer.

[1]  K. Yamamoto,et al.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.

[2]  Ana Filipa Costa,et al.  [Small cell lung cancer--state of the art and future perspectives]. , 2007, Revista portuguesa de pneumologia.

[3]  A. Keating,et al.  Comprehensive Identification of Human bZIP Interactions with Coiled-Coil Arrays , 2003, Science.

[4]  Kanefusa Kato,et al.  Aldolase C in neuroendocrine tumors: an immunohistochemical study , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[5]  A. Spassky,et al.  Nuclease activity of 1,10-phenanthroline-copper ion. Conformational analysis and footprinting of the lac operon. , 1985, Biochemistry.

[6]  D. Bennett,et al.  The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. , 1995, Oncogene.

[7]  Richard H. Lathrop,et al.  DNA sequence and structure: direct and indirect recognition in protein-DNA binding , 2002, ISMB.

[8]  Wyeth W. Wasserman,et al.  In silico identification of metazoan transcriptional regulatory regions , 2003, Naturwissenschaften.

[9]  R. Marais,et al.  The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation , 2004, Molecular and Cellular Biology.

[10]  M. Katoh,et al.  Human FOX gene family (Review). , 2004, International journal of oncology.

[11]  L. Lim,et al.  Transcription factors in mouse lung development and function. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[12]  P. Privalov,et al.  DNA binding and bending by HMG boxes: energetic determinants of specificity. , 2004, Journal of molecular biology.

[13]  S. Millevoi,et al.  Atypical binding of the neuronal POU protein N-Oct3 to noncanonical DNA targets. Implications for heterodimerization with HNF-3 beta. , 2001, European journal of biochemistry.

[14]  C. Gridelli,et al.  The role of new targeted therapies in small-cell lung cancer. , 2004, Critical reviews in oncology/hematology.

[15]  W. Herr,et al.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.

[16]  G. Chrousos,et al.  Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing’s syndrome , 1994, Journal of endocrinological investigation.

[17]  Jeffrey A Whitsett,et al.  Foxa2 is required for transition to air breathing at birth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Magali Blaud,et al.  Characteristic patterns of N Oct-3 binding to a set of neuronal promoters. , 2004, Journal of molecular biology.

[19]  D. Sigman,et al.  Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. , 1987, Biochemistry.

[20]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[21]  D S Latchman,et al.  Transcription factors as potential targets for therapeutic drugs. , 2000, Current pharmaceutical biotechnology.

[22]  J. Darnell Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[23]  R. Palmiter,et al.  Identification of a neuron-specific promoter of human aromatic L-amino acid decarboxylase gene. , 1993, Brain research. Molecular brain research.

[24]  G Vriend,et al.  New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. , 1998, Genes & development.

[25]  Steven Hahn,et al.  Structure and mechanism of the RNA polymerase II transcription machinery , 2004, Nature Structural &Molecular Biology.

[26]  S. Khorasanizadeh,et al.  Nuclear-receptor interactions on DNA-response elements. , 2001, Trends in biochemical sciences.

[27]  R. Thompson,et al.  Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. , 1987, Molecular endocrinology.

[28]  H. Niwa,et al.  Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. , 2002, Nucleic acids research.

[29]  K. Jishage,et al.  The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. , 1995, Genes & development.

[30]  T. Eulgem Eukaryotic transcription factors , 2001, Genome Biology.

[31]  Juli D. Klemm,et al.  Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules , 1994, Cell.

[32]  R. Stahel,et al.  Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (brain-2). , 1992, Cancer research.

[33]  Anna G. Nazina,et al.  Distance preferences in the arrangement of binding motifs and hierarchical levels in organization of transcription regulatory information. , 2003, Nucleic acids research.

[34]  M. Rosenfeld,et al.  POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. , 2001, Endocrine reviews.

[35]  H. Hamada,et al.  A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages , 1993, Neuron.

[36]  S. Burley,et al.  Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 , 1993, Nature.

[37]  G. Sutherland,et al.  The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. , 1995, Oncogene.

[38]  O. Kohlbacher,et al.  From sequence to structure and back again: approaches for predicting protein-DNA binding , 2004, Proteome Science.

[39]  K. Kaestner,et al.  Foxa2 regulates multiple pathways of insulin secretion. , 2004, The Journal of clinical investigation.

[40]  Alexander E. Kel,et al.  TRANSCompel®: a database on composite regulatory elements in eukaryotic genes , 2002, Nucleic Acids Res..

[41]  M Wilmanns,et al.  Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. , 2001, Molecular cell.

[42]  E. D. Hyman A new method of sequencing DNA. , 1988, Analytical biochemistry.

[43]  C. Garvie,et al.  Recognition of specific DNA sequences. , 2001, Molecular cell.

[44]  Wouter de Laat,et al.  Linker length and composition influence the flexibility of Oct‐1 DNA binding , 1997, The EMBO journal.

[45]  J. Jameson,et al.  Transcriptional Control of Gene Expression , 1998 .

[46]  D. Latchman,et al.  POU family transcription factors in the nervous system , 1999, Journal of cellular physiology.

[47]  Akihiko Okuda,et al.  The Gene for the Embryonic Stem Cell Coactivator UTF1 Carries a Regulatory Element Which Selectively Interacts with a Complex Composed of Oct-3/4 and Sox-2 , 1999, Molecular and Cellular Biology.

[48]  H. Novotná,et al.  Expression of the aromatic L-amino acid decarboxylase mRNA in human tumour cell lines of neuroendocrine and neuroectodermal origin. , 1997, European journal of cancer.

[49]  M. Rosenfeld,et al.  Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. , 2000, Science.

[50]  M. Rosenfeld,et al.  Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. , 1997, Genes & development.

[51]  E. Turner,et al.  Highly Cooperative Homodimerization Is a Conserved Property of Neural POU Proteins* , 1998, The Journal of Biological Chemistry.

[52]  S. Levy,et al.  Predicting transcription factor synergism. , 2002, Nucleic acids research.

[53]  T. Eisen The control of gene expression in melanocytes and melanomas. , 1996, Melanoma research.

[54]  Guillaume Paillard,et al.  Analyzing protein-DNA recognition mechanisms. , 2004, Structure.

[55]  J. Whitsett,et al.  Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors. , 2004, Human pathology.

[56]  A. Spassky,et al.  DNA-stacking interactions determine the sequence specificity of the deoxyribonuclease activity of 1,10-phenanthroline-copper ion. , 1996, Journal of molecular biology.

[57]  D. Ambrosetti,et al.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites , 1997, Molecular and cellular biology.

[58]  R Lavery,et al.  The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. , 1988, Journal of biomolecular structure & dynamics.

[59]  Matthias Wilmanns,et al.  Synergism with the Coactivator OBF-1 (OCA-B, BOB-1) Is Mediated by a Specific POU Dimer Configuration , 2000, Cell.

[60]  A. Sommer,et al.  Aspects of lung cancer gene expression profiling. , 2004, Current opinion in drug discovery & development.

[61]  P. Sawchenko,et al.  Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. , 1995, Genes & development.

[62]  S. Selvaraj,et al.  Specificity of protein-DNA recognition revealed by structure-based potentials: symmetric/asymmetric and cognate/non-cognate binding. , 2002, Journal of molecular biology.

[63]  Eisen Tg The control of gene expression in melanocytes and melanomas. , 1996 .

[64]  Michal Galdzicki,et al.  Mammalian overlapping genes: the comparative perspective. , 2004, Genome research.

[65]  T. Moody,et al.  Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells , 1994, Peptides.